 Moderna is getting $176 million from the Department of Health and Human Services to accelerate development of a pandemic influenza vaccine that would be used to treat bird flu in people. Officials say the project can be quickly redirected to target another form of influenza if a different threat than the H5N1 form of bird flu emerges.